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Introduction 
Leukemic meningitis is a rare 
complication of chronic lymphocytic 
leukemia (CLL).1-2 The incidence of 
meningeal disease was 1% for patients with 
CLL in a retrospective Scandinavian study.3 
The major components of treatment are 
intrathecal methotrexate and cranial 
irradiation.1,4,5 Complete resolution is 
attainable with no adverse neurologic 
sequelae. 
 
Case Report 
A 44-year-old male known to have CLL 
developed altered mental status six days 
after being admitted for neutropenic fever 
and herpes zoster.  The patient’s CLL was 
diagnosed four years prior to admission and 
initially treated with cyclophosphamide, 
vincristine, and prednisone (CVP) 
chemotherapy. His CLL was CD38 (+) 
which is indicative of a more aggressive 
course.  He achieved remission, but relapsed 
three years later.  
At that time, the patient was treated with 
fludarabine-cyclophosphamide to remission. 
The most recent relapse was about one year 
later.  He was treated with pentostatin.  The 
disease progressed 14 days after the 
administration of pentostatin. One month 
later, the patient was treated with salvage 
rituximab/hyper-CVAD (cyclophosphamide, 
vincristine, doxorubicine and dexameth-
asone) part B. Afterward, the patient was 
lost to follow up and missed the second 
cycle  of  chemotherapy.    His  whereabouts  
 
were unknown for three months until he 
presented to the emergency room 
complaining of abdominal pain, nausea, 
vomiting, and severe fatigue.  
The physical exam revealed a 
temperature of 103oF, ulceration of the 
posterior palate, supraclavicular adenopathy, 
splenomegaly palpated six centimeters 
below the costal margin, and an extensive 
vesicular dermatomal infiltrate extending 
from the midline of the back around the 
right flank to the midline of the abdomen. 
Similar lesions were noted over the trunk, 
right axilla, face, and scalp.  
A complete blood count showed a white 
count of 13,500 (4% neutrophils); 
hemoglobin and hematocrit were 10.9 and 
33.1 respectively.  Sodium was 130, calcium 
was 11.9, and albumin 3.2 (corrected 
calcium = 12.86).  The patient was admitted 
and started on IV vancomycin and cefepime 
for his neutropenic fever, IV acyclovir for 
his herpes zoster, IV fluids for his 
hypercalcemia (parathyroid hormone-related 
protein mediated response), and allopurinol 
to alleviate the effects of potential tumor 
lysis syndrome.  
The patient had visual hallucinations 
(e.g., seeing animals) with confusion and 
agitation six days after admission.  He had a 
history of alcoholism and was transferred to 
the intensive care unit, restrained, and 
treated with an alcohol withdrawal protocol.  
However, he showed no improvement. 
Interestingly,  the patient told the nurses that  
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he was not having  alcohol withdrawal as his  
previous experience with it was very 
different. 
Given the presence of neutropenic fever, 
herpes zoster, and no improvement on the 
alcohol withdrawal protocol, a lumbar 
puncture was performed.  It revealed 
glucose of 25, protein of 55, lactate 
dehydrogenase of 19, white count of 187 
(95% of lymphocytes, 4% atypical 
lymphocytes) and the cerebrospinal (CSF) 
cytology revealed atypical lymphocytes.   
The patient received hyper-CVAD cycle 
two. Intrathecal methotrexate 6mg was 
administered twice weekly.  He had 
immediate resolution of the neurologic 
symptoms.  Within 40 days, he manifested 
subsequent clearing of malignant cells in the 
cerebrospinal fluid and a Karnofsky score of 
100 (i.e., no sign of disease). 
 
Discussion 
The differential diagnosis for the altered 
mental status in this case was broad.  
Alcohol withdrawal topped the list as the 
patient was an alcoholic having 
hallucinations after six days in the hospital.  
The lumbar puncture was necessary to 
reveal the leukemic meningitis.  
The manner in which leukemic cells 
enter the central nervous system (CNS) is a 
subject of controversy, but the likely sources 
include hematogenous spread or direct 
spread from adjacent infiltrated bone 
marrow. The most common form of CNS 
spread or meningeal form of leukemia are 
divided in four categories: increased intra-
cranial pressure (with vomiting, headache, 
papilledema, lethargy, seizure, and/or 
coma), visual disturbances (with diplopia, 
blurred vision, blindness, and/or 
photophobia), CNS palsies (e.g., in cranial 
nerves VI or VII), and other (with 
myelopathy, auditory, vertigo, ataxia, 
hallucinations, and/or nystagmus).6 
The major components of the treatment 
for leukemic meningitis in CLL are 
intrathecal methotrexate and cranial 
irradiation.1,4,5  Intrathecal steroids were 
used to treat the chemotherapy-induced 
encephalopathy.2,5,7  Rituximab was reported 
to be effective in a case refractory to the 
conventional chemotherapy.7 Fludarabine 
also was suggested to be helpful in inducing 
durable remission in patients with 
leptomeningeal involvement of CLL.8 
The present case illustrated that a 
complete resolution of the leukemic 
meningitis associated with CLL is attainable 
with intrathecal methotrexate with no 
adverse neurologic sequelae. 
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